P2RX4 and neuropathy: Indeed, CB2R activation in a paclitaxel model of chemotherapy-induced neuropathy leads to decreased IL-6, BDNF, P2X4, and TNFα receptor expression, and increased release of the anti-inflammatory cytokine IL-10 (Burgos et al., 2012; Wu et al., 2019).